
Monoface SB 1000mg/500mg Injection
Marketer
Menrik Biomerge Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Monoface SB 1000mg/500mg Injection
Combiflox SB, a 1000mg/500mg injectable formulation, combats bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, this dual-action medication requires adherence to the prescribed schedule. Complete the entire course, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions (rash, itching, swelling, dyspnea). Disclose all current medications to your physician before commencing treatment, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing to driving, refrain from operating vehicles if experiencing somnolence or dizziness. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor may order tests to monitor therapeutic response.
Primary Ingredients of Monoface SB 1000mg/500mg Injection
There is no text provided to rephrase.
Uses of Monoface SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Monoface SB 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Monoface SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Monoface SB 1000mg/500mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Monoface SB 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Monoface SB 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Monoface SB 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Monoface SB (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, research involving human subjects is currently insufficient.
Breast feedingCAUTION
The administration of Monoface SB 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Monoface SB 1000mg/500mg Injection might induce drowsiness, visual disturbances, or dizziness. Driving is discouraged if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on the administration of Monoface SB 1000mg/500mg Injection to individuals with renal impairment is scarce. Seek medical advice.
LiverCAUTION
The 1000mg/500mg Monoface SB injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for this injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Monoface SB 1000mg/500mg Injection :
Should you forget a scheduled dose of Monoface SB 1000mg/500mg Injection, seek advice from your physician.
Facts to Know About Monoface SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobial Agents |
